Regulatory Strategy in Pharma in 2026: From Drug Development to GMP Inspection Readiness
October 10, 2026
Effective regulatory planning connects drug development, CMC, submissions, manufacturing, and lifecycle obligations. This article explains how regulatory teams can reduce compliance gaps, prepare for inspections, manage post-approval changes, and make better decisions across the pharmaceutical product lifecycle.